Boxed warning for potential HBV reactivation added to Arzerra, Rituxan labeling Healio Rituxan (rituximab, Genentech) is a therapy for CLL, non-Hodgkin's lymphoma and conditions that include microscopic polyangiitis, granulomatosis with polyangiitis and rheumatoid arthritis. These drugs, along with other CD20-directed cytolytic ... |
